Prognostic value of fluorodeoxyglucose uptake in non-small cell lung cancer: time for standardization and validation.
?
['Carcinoma, Non-Small-Cell Lung/*diagnostic imaging/mortality', 'Fluorodeoxyglucose F18/*pharmacokinetics', 'Humans', 'Lung Neoplasms/*diagnostic imaging/mortality', 'Positron-Emission Tomography', 'Prognosis', 'Radiopharmaceuticals/*pharmacokinetics', 'Survival Rate', 'Validation Studies as Topic']